The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
People with Parkinson's who actually have selective deficits of dopamine within the substantia nigra. Nigrostriatal, remember, it's substantia nigra show deficits in what? In movement. In the smoothness of movement. Oftentimes they won't blink at all. They'll have a blank stare.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.